Selasa, 02 Mei 2023

$4 stock (urgent opportunity)

Trade of the Day Wake-Up Watchlist

$4 Stock (Urgent Opportunity)

A compound originally isolated from an Ethiopian shrub called Maytenus ovatus

Is now part of the formula of a breakthrough cancer treatment.

It just recently received accelerated FDA approval.

Click here for the full story (including the $4 stock behind this breakthrough).

Yours in smart speculation,

Ryan Fitzwater Signature

Ryan Fitzwater, Publisher
Monument Traders Alliance

P.S. We've all heard the stories of scientists discovering cancer-fighting compounds in nature...

But rarely do we hear about where that research ends up.

This newly-approved drug uses Maytenus ovatus to infiltrate cancer cells and destroy them from the inside.

Here's why some go so far as to call it a "miracle"...

  • It's the first new treatment for this type of cancer since 2014...
  • A significant portion of patients went into full remission...
  • The drug costs 97.5% less than other next gen cancer treatments like CAR-T...
  • All with far less severe side effects!

Alexander Green from The Oxford Club believes this tiny stock won't be $4 for long.

Analysts agree.

The average price target is $12... a triple from current prices.

Guggenheim predicts it could go to $22 in as little as one year.

Click here to get all the details.

Tidak ada komentar:

Posting Komentar